Metraipolis › archive › dc_a5b3917210bb

Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial — Europe PMC PMID:41326666

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41326666
DOI
10.1038/s41591-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-08T03:29:11.912Z
SHA-256 of the archived text
4798b51e619078c0278ffb347f8e8024ae0c275ea99d4fa18e2dcd0a22c57a34
Stable URL of this page
https://metraipolis.com/documento/dc_a5b3917210bb

How to cite

Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial — Europe PMC PMID:41326666 — Europe PMC (en), https://europepmc.org/article/MED/41326666 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a5b3917210bb (Metraipolis archive dc_a5b3917210bb, sha256 4798b51e619078c0278ffb347f8e8024ae0c275ea99d4fa18e2dcd0a22c57a34)
BibTeX
@misc{dca5b3917210bb,
  title = {Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial — Europe PMC PMID:41326666},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41326666},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a5b3917210bb; sha256 4798b51e619078c0278ffb347f8e8024ae0c275ea99d4fa18e2dcd0a22c57a34},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41326666. Agents can read the archived copy with the MCP tool read_document.